Results 141 to 150 of about 55,053 (308)

CRISPR/Cas9, a powerful tool to target human herpesviruses

open access: yesCellular Microbiology, 2017
Over 90% of the adult population is infected with one or multiple herpesviruses. These viruses are characterized by their ability to establish latency, where the host is unable to clear the invader from infected cells resulting in a lifelong infection ...
Ferdy R. Diemen, R. Lebbink
semanticscholar   +1 more source

Lichen Planus Following COVID‐19 Infection and Vaccination. Matched Case–Control Study

open access: yesAustralasian Journal of Dermatology, Volume 66, Issue 5, Page 289-295, August 2025.
ABSTRACT Background New‐onset lichen planus (LP) development following COVID‐19 infection/vaccination is reported. Since case series cannot be used to study exposure–outcome associations, we designed this matched case–control study to investigate whether COVID‐19‐related events and de novo LP are associated.
Paolo Giacomo Arduino   +4 more
wiley   +1 more source

Herpesviruses and the Type III Interferon System

open access: yesVirologica Sinica, 2021
Yue Yin, H. Favoreel
semanticscholar   +1 more source

Beta and Gamma Human Herpesviruses: Agonistic and Antagonistic Interactions with the Host Immune System

open access: yesFrontiers in Microbiology, 2018
Viruses are the most abundant and diverse biological entities in the planet. Historically, our main interest in viruses has focused on their pathogenic role, recognized by pandemics that have decimated the world population. However, viral infections have
M. Cruz-Munoz, E. Fuentes-Pananá
semanticscholar   +1 more source

Cryptococcal meningitis due to Cryptococcus neoformans VNI in a koala (Phascolarctos cinereus) with progressive neurological disease

open access: yesAustralian Veterinary Journal, Volume 103, Issue 8, Page 487-493, August 2025.
Nearly all cases of cryptococcosis in koalas are caused by Cryptococcus gattii species complex. A rare case of meningitis due to Cryptococcus neoformans VNI/AFLP1 (abbreviated VNI) is described in a koala with nasal colonisation by both species complexes.
A Teh   +6 more
wiley   +1 more source

MORC3, a component of PML nuclear bodies, has a role in restricting herpes simplex virus type 1 and human cytomegalovirus [PDF]

open access: yes, 2016
We previously reported that MORC3, a protein associated with promyelocytic leukemia nuclear bodies (PML NBs), is a target of HSV-1 ICP0 mediated degradation.
Everett, Roger   +2 more
core   +1 more source

T cells from newly diagnosed multiple sclerosis patients have enhanced responsiveness to CD46 activation

open access: yesClinical and Experimental Neuroimmunology, Volume 16, Issue 3, Page 214-226, August 2025.
Abstract Objective To evaluate the responsiveness of T cells from newly diagnosed multiple sclerosis (MS) patients to CD46 co‐stimulation, a membrane co‐factor protein potentially involved in MS pathogenesis. Methods T cells from MS patients and non‐diseased symptomatic controls (SC) were activated in vitro with or without αCD46 antibody co‐stimulation.
Linda Sundvall   +6 more
wiley   +1 more source

Opportunisticheskaya gerpes-virusnaya infektsiya v patogeneze uveitov u detey s yuvenil'nym khronicheskim artritom

open access: yesНаучно-практическая ревматология, 2003
Objective. To reveal frequency of reactivation of persistent HSV type 1, 2 and CMV infections and to estimate its role in pathogenesis of rheumatoid uveitis in children with JCA. Material and methods.
G. L. Krichevskaya   +8 more
doaj   +1 more source

Comparison of Four Horse Herpesviruses [PDF]

open access: bronze, 1969
G. Plummer   +2 more
openalex   +1 more source

Differential diagnosis difficulties of focal central nervous system damage in children (а сlinical case)

open access: yesРусский журнал детской неврологии, 2018
Focal central nervous system damage can be a result of infectious process in brain or spinal cord, autoimmune or hypoxic-ischemic process and a relationship of these processes.
E. Yu. Skripchenko   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy